CytoSorbents
CTSO0.36544.37% ( +0.0153 )
CytoSorbents (CTSO)
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the U...
- Open
- 0.3800
- High
- 0.3800
- Low
- 0.3600
- Prev. Close
- 0.3501
- Volume
- 48.10K
- Turnover
- 18.09K
- Avg Price
- 0.3762
- Bid/Ask Ratio
- --
- Amplitude
- 5.71%
- 52wk High
- 1.2200
- Volume Ratio
- 8.19
- Turnover Ratio
- 0.09%
CytoSorbents Analyst Rating
View MoreForecast & Rating
May 21, 2026Price forecast
$2.88696.62%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 20 at 06:00 AM
CytoSorbents updates financial calendar with Q2 results release, conference call scheduled
- Global Report · Jul 7 at 05:38 AM
The AI Hangover Is Over: Finding Actual ROI in Tech and Fintech
- PUBT · Jul 6 at 03:06 PM
CytoSorbents gets Nasdaq notice for falling below $35 million market value threshold
- Tip Ranks · Jun 25 at 08:48 AM
CytoSorbents Advances FDA Pathway for DrugSorb Programs
- PUBT · Jun 25 at 08:28 AM
CytoSorbents posts investor presentation outlining blood purification products, DrugSorb-ATR regulatory path
- Simplywall · Jun 22 at 05:56 AM
Insider Spends US$105k Buying More Shares In Cytosorbents
